Table 5.
Formulation | Days | Drug content (%)
|
||
---|---|---|---|---|
2°C–8°C | 25°C | 40°C±2°C/75%±5% RH | ||
TPH gel | 0 | 99.72±2.61 | 99.72±2.61 | 99.72±2.61 |
5 | 99.61±2.35 | 98.55±1.51 | 95.92±1.16 | |
10 | 99.34±1.94 | 97.68±1.01 | 92.16±2.18 | |
15 | 98.95±1.99 | 96.81±0.71 | 87.98±1.22 | |
30 | 98.05±2.11 | 95.28±1.39 | 80.81±0.59 | |
FPH gel | 0 | 99.79±2.18 | 99.79±2.18 | 99.79±2.18 |
5 | 99.74±1.50 | 99.43±2.60 | 98.04±1.82 | |
10 | 99.69±2.59 | 98.74±1.59 | 96.19±0.55 | |
15 | 99.58±0.68 | 98.19±1.74 | 92.77±1.56 | |
30 | 99.26±1.25 | 97.13±1.82 | 85.55±1.97 |
Note: The values were the means ± standard deviation from three parallel measurements.
Abbreviations: TPH, transferosomal papaverine hydrochloride; FPH, free papaverine hydrochloride; RH, relative humidity.